Avadel Pharma Completes $1B Acquisition of Avadel Holdings
| Field | Detail |
|---|---|
| Company | Avadel Pharmaceuticals PLC |
| Form Type | 8-K |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, subsidiary, corporate-action
TL;DR
Avadel just bought out the rest of its subsidiary for $1B, now owns 100%.
AI Summary
Avadel Pharmaceuticals PLC announced on May 6, 2025, that it has completed its previously announced acquisition of the remaining 50% interest in its subsidiary, Avadel Holdings plc, for approximately $1.0 billion. This transaction consolidates full ownership of Avadel Holdings plc under Avadel Pharmaceuticals PLC.
Why It Matters
This move consolidates Avadel's ownership structure, potentially simplifying operations and financial reporting, and may signal a strategic shift towards greater integration of its subsidiary's assets.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a completed acquisition, with no immediate new risks identified.
Key Numbers
- $1.0B — Acquisition Cost (Represents the total value paid for the remaining 50% interest in Avadel Holdings plc.)
Key Players & Entities
- Avadel Pharmaceuticals PLC (company) — Registrant
- Avadel Holdings plc (company) — Subsidiary being acquired
- $1.0 billion (dollar_amount) — Acquisition price
- May 6, 2025 (date) — Date of report and transaction completion
FAQ
What was the exact date of the acquisition completion?
The acquisition was completed on May 6, 2025.
What was the total value of the acquisition?
The acquisition of the remaining 50% interest in Avadel Holdings plc was for approximately $1.0 billion.
What is the relationship between Avadel Pharmaceuticals PLC and Avadel Holdings plc after the transaction?
Avadel Pharmaceuticals PLC now owns 100% of Avadel Holdings plc.
What type of filing is this?
This is a Form 8-K, a current report filed with the SEC.
What is the principal executive office address of Avadel Pharmaceuticals PLC?
The address is 10 Earlsfort Terrace, Dublin 2, Ireland, D02 T380.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding AVADEL PHARMACEUTICALS PLC.